Biogen Inc. - Company & Market Research Reports

Home /
Companies /
Biogen Inc.

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 148
Genomics 73
Biopharmaceuticals 72
Immune Disorders Drugs 71
Biotechnology 50
Musculoskeletal Disorders Drugs 42
Oncology Drugs 40
Pharmaceuticals 40
Drug Discovery 37
Hematological Drugs 36
Biosimilars and Biosuperiors 31
Alzheimer's Disease Drugs 26
Infusions and Injectables 25
Allergy and Immunology 23
Cardiovascular Drugs 23
Optical Disorders Drugs 21
Clinical Trials 21
Mental Disorders Drugs 19
Neurology 17
Needles and Syringes 17
E-Healthcare 14
Respiratory Drugs 14
Psoriasis Drugs 14
Optical 13
Infectious Diseases Drugs 12
Immunosuppressive Drugs 12
Healthcare Services 11
Analgesics 11
Hematology 11
Gastrointestinal Drugs 11
Drug Delivery 10
Pharmaceutical Manufacturing 10
Lymphoma Drugs 9
Diagnostics 9
Endocrine and Metabolic Disorders Drugs 9
Therapeutic Area 8
Drugs by Therapeutic Area 8
Leukemia Drugs 8
Pulmonary Medicine 7
Liver and Kidney Disorders Drugs 7
Medical Devices 6
Enzymes 5
Neurology Devices 5
Oncology 5
Schizophrenia Drugs 5
Company Reports 4
Proteomics 4
Mental Health 4
Cardiology 4
Pharmaceutical Intermediates 3
Generic Drugs 3
Stem Cells 3
Hospital Management 3
Dermatology 3
Vitamins and Dietary Supplements 3
Gastroenterology 3
Dermatological Drugs 3
Urology and Nephrology 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
In Vitro Diagnostics 2
Managed Care 2
Diabetes Devices 2
Biomaterials 2
Biomarkers 2
Vaccines 2
Skin Cancer Drugs 2
Laboratory Equipment 2
Anxiety Drugs 2
Addiction Disorders Drugs 1
Diabetes Drugs 1
Women's Health 1
Fertility Services 1
Lung Cancer Drugs 1
Colon Cancer Drugs 1
Cervical Cancer Drugs 1
Brain Cancer Drugs 1
Medical Imaging 1
Infectious Disease Testing 1
Transdermal and Transmucosal Drug Delivery 1
Surgical Devices 1
Contrast Media 1
Kidney Cancer Drugs 1
Nanomedicine 1
Antibiotics 1
Clinical Skills 1
Palliative Care 1
Pediatrics 1
Anatomy 1
Endocrinology 1
Allergy Drugs 1
Asthma Drugs 1
Sexual and Reproductive Health Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



282 reviews

848 Results (Page 34 of 43)
- Relevance
  Sort by

RNA Interference- Pipeline Insight, 2025

 Drug Pipelines
April 2025
204 Pages
Global

From

€2707EUR$3,000USD£2,352GBP

Recombinant DNA Technology Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4052EUR$4,490USD£3,520GBP

Solid Tumor Cancer Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4052EUR$4,490USD£3,520GBP

Myeloproliferative Disorders Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4052EUR$4,490USD£3,520GBP

Targeted Therapy Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4052EUR$4,490USD£3,520GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Thrombotic Thrombocytopenic Purpura - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1128EUR$1,250USD£980GBP

Lou Gehrig's Disease - Pipeline Insight, 2025

 Clinical Trials
April 2025
240 Pages
Global

From

€2707EUR$3,000USD£2,352GBP

Hemophilia Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030

 Report
August 2022
Global

From

€4061EUR$4,500USD£3,528GBP

Leukemia Treatment Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
95 Pages
Global

From

€3500EUR$4,155USD£3,147GBP

Neuroprotection Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

 Report
March 2024
90 Pages
Global

From

€3500EUR$4,155USD£3,147GBP

Tumor Necrosis Factor Inhibitor Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4052EUR$4,490USD£3,520GBP

Chemotherapy Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4052EUR$4,490USD£3,520GBP

Systemic Lupus Erythematosus Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023- 2028)

 Report
April 2023
115 Pages
Global

From

€4287EUR$4,750USD£3,724GBP

Histoplasmosis Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4052EUR$4,490USD£3,520GBP

Biobetter Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2023
112 Pages
Global

From

€3500EUR$4,155USD£3,147GBP

Antibody Drug Conjugates Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4052EUR$4,490USD£3,520GBP

Antisense And RNAi Therapeutics Market Size, Share & Trends Analysis Report By Technology (RNA Interference, Antisense RNA), By Application (Ocular, Genetic), By Route of Administration (Intrathecal, Intravenous), By Region, And Segment Forecasts, 2024 - 2030

 Report
February 2024
130 Pages
Global

From

€5370EUR$5,950USD£4,665GBP

Multiple System Atrophy (MSA) - Market Insight, Epidemiology, and Market Forecast - 2034

 Report
January 2025
194 Pages
Global

From

€7174EUR$7,950USD£6,233GBP

Advanced Therapy Medicinal Products Market Size, Share & Trends Analysis Report by Therapy Type (Cell Therapy, Gene Therapy, Tissue Engineered Product), Region (North America, Europe, APAC, ROW), and Segment Forecasts, 2023-2030

 Report
December 2023
120 Pages
Global

From

€5370EUR$5,950USD£4,665GBP

Orphan Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4052EUR$4,490USD£3,520GBP

848 Results (Page 34 of 43)
- 1
- 32
- 33
- 34
- 35
- 36

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.